Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management, Clinical Microbiology Reviews, vol.28, issue.3, p.60361, 2015. ,
DOI : 10.1128/CMR.00134-14
URL : http://cmr.asm.org/content/28/3/603.full.pdf
Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey, Clinical Infectious Diseases, vol.54, issue.9, p.12309, 2012. ,
DOI : 10.1093/cid/cis199
URL : https://hal.archives-ouvertes.fr/hal-00825451
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 9 oct, p.173654, 2007. ,
Med Lett Drugs Ther, p.5960, 1213. ,
2015 ESC Guidelines for the management of infective endocarditis, Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 21 nov, p.3075128, 2015. ,
DOI : 10.1093/eurheartj/ehv319
URL : https://hal.archives-ouvertes.fr/hal-01466878
Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review Disponible sur, PLoS ONE, vol.8, issue.12 ,
DOI : 10.1371/journal.pone.0082665
URL : https://doi.org/10.1371/journal.pone.0082665
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century, Archives of Internal Medicine, vol.169, issue.5, p.46373, 2009. ,
DOI : 10.1001/archinternmed.2008.603
URL : https://hal.archives-ouvertes.fr/hal-00464774
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?, European Heart Journal, vol.32, issue.16, 2011. ,
DOI : 10.1093/eurheartj/ehp008
URL : https://hal.archives-ouvertes.fr/hal-00733918
Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications, Journal of the American College of Cardiology, vol.59, issue.22, p.196876, 2012. ,
DOI : 10.1016/j.jacc.2012.02.029
URL : https://hal.archives-ouvertes.fr/hal-00825449
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer, Eur Heart J. oct, vol.30, p.2369413, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00465409
Infective endocarditis. The Lancet. 10 janv, p.13949, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00465409
A Systematic Review of Population-Based Studies of Infective Endocarditis, Chest, vol.132, issue.3, p.102535, 2007. ,
DOI : 10.1378/chest.06-2048
Changing Patient Characteristics and the Effect on Mortality in Endocarditis, Archives of Internal Medicine, vol.162, issue.1, p.904, 2002. ,
DOI : 10.1001/archinte.162.1.90
Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens, Heart, vol.91, issue.7, p.9327, 2005. ,
DOI : 10.1136/hrt.2004.042648
Mechanisms of infective endocarditis: pathogen???host interaction and risk states, Nature Reviews Cardiology, vol.89, issue.1, p.3550, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.108.773598
Staphylococcus aureus. Editions Médicales internationales, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01454440
Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions, Journal of Medical Microbiology, vol.51, issue.9, p.74754, 2002. ,
DOI : 10.1099/0022-1317-51-9-747
Staphylococcus aureus Develops an Alternative, ica-Independent Biofilm in the Absence of the arlRS Two-Component System, Journal of Bacteriology, vol.187, issue.15, p.531829, 2005. ,
DOI : 10.1128/JB.187.15.5318-5329.2005
Obstruction of the Left Main Coronary Ostium Due to an Aortic Vegetation: Survival After Early Surgery, Clinical Infectious Diseases, vol.22, issue.1, p.1923, 1996. ,
DOI : 10.1093/clinids/22.1.192
Predictive risk factors for periannular extension of native valve endocarditis. Clinical and echocardiographic analyses, Chest. déc, vol.96, issue.6, p.12739, 1989. ,
Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study, Circulation. 5 juill, vol.112, issue.1, p.6975, 2005. ,
Cerebrovascular Complications in Patients with Left???Sided Infective Endocarditis Are Common: A Prospective Study Using Magnetic Resonance Imaging and Neurochemical Brain Damage Markers, Clinical Infectious Diseases, vol.47, issue.1, p.2330, 2008. ,
DOI : 10.1086/588663
Neurological Complications of Infective Endocarditis: Risk Factors, Outcome, and Impact of Cardiac Surgery: A Multicenter Observational Study, Circulation, vol.127, issue.23, p.227284, 2013. ,
DOI : 10.1161/CIRCULATIONAHA.112.000813
Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges, Brain J Neurol. oct, vol.112, p.1295315, 1989. ,
Platelet Interaction with Bacteria, Am J Pathol. nov, vol.65, issue.2, p.36780, 1971. ,
Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation, pp.121928-121929, 2013. ,
Platelets and Infections ???????? Complex Interactions with Bacteria, Frontiers in Immunology, vol.14, issue.10????????12, 4341565. ,
DOI : 10.1038/ni.2631
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2015.00082/pdf
Platelet interaction with bacteria. IV. Stimulation of the release reaction, Am J Pathol. nov, vol.81, issue.2, p.41120, 1975. ,
Platelet interaction with bacteria. V. Ultrastructure of congenital afibrinogenemic platelets, Am J Pathol. janv, vol.98, issue.1, 1980. ,
Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation, Blood, vol.99, issue.11, p.40219, 2002. ,
DOI : 10.1182/blood-2001-12-0191
An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation, Thrombosis Research, vol.122, issue.6, p.8109, 2008. ,
DOI : 10.1016/j.thromres.2008.03.011
Molecular Basis for Staphylococcus aureus-Mediated Platelet Aggregate Formation Under Arterial Shear In Vitro, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.2, p.33540, 2008. ,
DOI : 10.1161/ATVBAHA.107.152058
Fibronectinbinding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor, Mol Microbiol. janv, vol.59, issue.1, p.21230, 2006. ,
Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets, Microbiology, vol.156, issue.3, p.9208, 2010. ,
DOI : 10.1099/mic.0.036673-0
Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in Binding to Human Platelets, Infection and Immunity, vol.73, issue.4, p.227380, 2005. ,
DOI : 10.1128/IAI.73.4.2273-2280.2005
Coordinated Molecular Cross-Talk between Staphylococcus aureus, Endothelial Cells and Platelets in Bloodstream Infection, Pathogens, vol.83, issue.4, p.86982 ,
DOI : 10.4049/jimmunol.173.2.1258
URL : http://www.mdpi.com/2076-0817/4/4/869/pdf
Staphylococciinduced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor, J Clin Invest. oct, vol.64, issue.4, p.9317, 1979. ,
DOI : 10.1172/jci109559
URL : http://www.jci.org/articles/view/109559/files/pdf
Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A ,
Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions, FEBS J. nov, vol.273, issue.21, p.483141, 2006. ,
Platelet???bacterial interactions, Cellular and Molecular Life Sciences, vol.99, issue.Suppl 1, p.51323, 2010. ,
DOI : 10.1111/j.1538-7836.2007.02867.x
Alpha-toxin of Staphylococcus aureus, Microbiol Rev. déc, vol.55, issue.4, p.73351, 1991. ,
Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation, Journal of Thrombosis and Haemostasis, vol.7, issue.6, p.1097107, 2011. ,
DOI : 10.1111/j.1538-7836.2008.03211.x
GPVI and GPIb?? Mediate Staphylococcal Superantigen-Like Protein 5 (SSL5) Induced Platelet Activation and Direct toward Glycans as Potential Inhibitors, PLoS ONE, vol.77, issue.4 ,
DOI : 10.1371/journal.pone.0019190.s001
URL : https://doi.org/10.1371/journal.pone.0019190
Crosstalk between platelets and the complement system in immune protection and disease, Thrombosis and Haemostasis, vol.110, issue.5, p.9109, 2013. ,
DOI : 10.1160/TH13-02-0102
Immunology and Cell Biology -Abstract of article: CR3 receptor on platelets and its role in the prostaglandin metabolic pathway, Immunol Cell Biol. déc, vol.65, issue.6, p.45360, 1987. ,
Human blood platelet gC1qR/p33, Immunological Reviews, vol.180, issue.1, p.5664, 2001. ,
DOI : 10.1034/j.1600-065X.2001.1800105.x
Human platelet activation by C3a and C3a des-arg, Journal of Experimental Medicine, vol.158, issue.2, p.60315, 1983. ,
DOI : 10.1084/jem.158.2.603
URL : http://jem.rupress.org/content/jem/158/2/603.full.pdf
Both Complement- and Fibrinogen-Dependent Mechanisms Contribute to Platelet Aggregation Mediated by Staphylococcus aureus Clumping Factor B, Infection and Immunity, vol.75, issue.7, p.333543, 2007. ,
DOI : 10.1128/IAI.01993-06
URL : http://iai.asm.org/content/75/7/3335.full.pdf
Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A, Molecular Microbiology, vol.432, issue.3, p.80418, 2005. ,
DOI : 10.1111/j.1365-2672.1993.tb05195.x
Staphylococcus aureus Protein A Recognizes Platelet gC1qR/p33: a Novel Mechanism for Staphylococcal Interactions with Platelets, Infection and Immunity, vol.68, issue.4, p.20618, 2000. ,
DOI : 10.1128/IAI.68.4.2061-2068.2000
Activation-dependent surface expression of gC1qR/p33 on human blood platelets, Thromb Haemost. févr, vol.89, issue.2, p.3319, 2003. ,
Platelets in defense against bacterial pathogens, Cellular and Molecular Life Sciences, vol.113, issue.Suppl 6B, p.52544, 2010. ,
DOI : 10.1093/infdis/168.4.910
URL : https://link.springer.com/content/pdf/10.1007%2Fs00018-009-0210-4.pdf
Purification and in vitro activities of rabbit platelet microbicidal proteins, Infect Immun. mars, vol.65, issue.3, p.102331, 1997. ,
Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins, Infect Immun. nov, vol.65, issue.11, p.465260, 1997. ,
Staphylococcus aureus elicits release of platelet microbicidal proteins in vitro, 1996. ,
Influence of Platelets and Platelet Microbicidal Protein Susceptibility on the Fate of Staphylococcus aureus in an In Vitro Model of Infective Endocarditis, Infection and Immunity, vol.68, issue.8, p.4699705, 2000. ,
DOI : 10.1128/IAI.68.8.4699-4705.2000
In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates., Antimicrobial Agents and Chemotherapy, vol.38, issue.4, p.72932, 1994. ,
DOI : 10.1128/AAC.38.4.729
In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source, J Infect Dis. oct, vol.182, issue.4, p.12514, 2000. ,
In Vitro Susceptibility to Thrombin-Induced Platelet Microbicidal Protein Is Associated With Reduced Disease Progression and Complication Rates in Experimental Staphylococcus aureus Endocarditis, Circulation. 12 févr, vol.105, issue.6, p.74652, 2002. ,
A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221???550) inhibits platelet-plug formation in mice, Thrombosis Research, vol.121, issue.2, p.18391, 2007. ,
DOI : 10.1016/j.thromres.2007.03.019
Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis, Infect Immun. avr, vol.61, issue.4, p.15935, 1993. ,
Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis, Antimicrobial Agents and Chemotherapy, vol.39, issue.8, p.1748, 1995. ,
DOI : 10.1128/AAC.39.8.1748
Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis, International Journal of Antimicrobial Agents, vol.11, issue.2, p.15961, 1999. ,
DOI : 10.1016/S0924-8579(98)00092-2
Prophylaxis of Experimental Endocarditis With Antiplatelet and Antithrombin Agents: A Role for Long-term Prevention of Infective Endocarditis in Humans?, Journal of Infectious Diseases, vol.211, issue.1, p.729, 2015. ,
DOI : 10.1093/infdis/jiu426
Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus, 2017. ,
DOI : 10.1093/femspd/ftv060
URL : https://academic.oup.com/femspd/article-pdf/73/8/ftv060/10750045/ftv060.pdf
Acetylsalicylic Acid Reduces Vegetation Bacterial Density, Hematogenous Bacterial Dissemination, and Frequency of Embolic Events in Experimental Staphylococcus aureus Endocarditis Through Antiplatelet and Antibacterial Effects, Circulation, vol.99, issue.21, p.27917, 1999. ,
DOI : 10.1161/01.CIR.99.21.2791
Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis, Clinical Infectious Diseases, vol.44, issue.9, p.11806, 2007. ,
DOI : 10.1086/513197
Chronic antiplatelet therapy and mortality among patients with infective endocarditis, Clinical Microbiology and Infection, vol.15, issue.2, p.1939, 2009. ,
DOI : 10.1111/j.1469-0691.2008.02665.x
URL : https://doi.org/10.1111/j.1469-0691.2008.02665.x
Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid, Journal of Infection, vol.58, issue.5, p.3328, 2009. ,
DOI : 10.1016/j.jinf.2009.03.006
Modifiers of Symptomatic Embolic Risk in Infective Endocarditis, Mayo Clinic Proceedings, vol.86, issue.11, p.106874, 2011. ,
DOI : 10.4065/mcp.2011.0111
Effect of Long-Term Aspirin Use on Embolic Events in Infective Endocarditis, Clinical Infectious Diseases, vol.46, issue.1, p.3741, 2008. ,
DOI : 10.1086/524021
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis, J Am Coll Cardiol. 3 sept, vol.42, issue.5, p.77580, 2003. ,
Risque embolique des endocardites infectieuses. mt cardio. mai-juin, p.23542, 2005. ,
Complications neurologiques des endocardites infectieuses, Disponible sur, 2009. ,
DOI : 10.1016/j.reaurg.2009.06.010
Structural Mechanism for Statin Inhibition of HMG-CoA Reductase, Science, vol.292, issue.5519, p.11604, 2001. ,
DOI : 10.1126/science.1059344
Statins as a newly recognized type of immunomodulator, Nat Med. déc, vol.6, issue.12, p.1399402, 2000. ,
Simvastatin Inhibits Leukocyte-Endothelial Cell Interactions and Protects Against Inflammatory Processes in Normocholesterolemic Rats, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.12, p.2894900, 1999. ,
DOI : 10.1161/01.ATV.19.12.2894
URL : http://atvb.ahajournals.org/content/atvbaha/19/12/2894.full.pdf
Effect of Statins on Platelet PAR-1 Thrombin Receptor in Patients With the Metabolic Syndrome (From the PAR-1 Inhibition by Statins [PARIS] Study), The American Journal of Cardiology, vol.97, issue.9, p.13326, 2006. ,
DOI : 10.1016/j.amjcard.2005.11.058
Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection, Critical Care Medicine, vol.44, issue.4, p.77381, 2016. ,
DOI : 10.1097/CCM.0000000000001554